Patrick Koo1, Paul Muntner2, Michael E Hall3, Annie Gjelsvik4, Franklin Dennis McCool5, Charles B Eaton6. 1. Department of Respiratory, Critical Care, and Sleep Medicine, Erlanger Baroness Hospital, University of Tennessee Health Science Center, Chattanooga, Tennessee, USA. 2. Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, Alabama, USA. 3. Division of Cardiovascular Diseases, University of Mississippi Medical Center, Jackson, Mississippi, USA. 4. Department of Epidemiology, Brown School of Public Health, Providence, Rhode Island, USA. 5. Division of Pulmonary, Critical Care, and Sleep Medicine, Memorial Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, Rhode Island, USA. 6. Department of Family Medicine and Epidemiology, Memorial Hospital of Rhode Island, Alpert Medical School of Brown University and Brown School of Public Health, Providence, Rhode Island, USA.
Abstract
BACKGROUND: African Americans have a higher prevalence of resistant hypertension compared with Caucasians. Racial differences in obstructive sleep apnea (OSA) and increased aldosterone level may explain the racial disparity in resistant hypertension prevalence. Therefore, the purpose of this study is to investigate if aldosterone level and hypertension status differ by risks for OSA (e.g., obesity, loud snoring, and daytime sleepiness) and how aldosterone level varies with hypertension severity and control among African Americans. METHODS: A cross-sectional analysis was performed using baseline data on 5,052 African American adults in the Jackson Heart Study to investigate the relationships of interest using multivariable linear and multinomial logistic regression models adjusted for potential confounders. Risks for OSA were defined by a "risk score" consisting of the number of risks for OSA. RESULTS: Of the 5,052 participants, 623 had no risks for OSA. Body mass index was the highest among those with a risk score of 6. About 39% of the sample had no hypertension, 29% had controlled hypertension, 26% had uncontrolled hypertension, and 6% had resistant hypertension. Higher odds of having uncontrolled hypertension or resistant hypertension were present in those with a higher risk score compared with those without risks for OSA. Log-aldosterone level increased with each additional risk for OSA (P-trend <0.05). Similarly, log-aldosterone also increased with more severe hypertension (P-trend <0.001). The highest aldosterone level was found in those with resistant hypertension that was inadequately controlled with medications. CONCLUSIONS: Risks for OSA were positively associated with resistant hypertension and higher aldosterone level in African American adults.
BACKGROUND: African Americans have a higher prevalence of resistant hypertension compared with Caucasians. Racial differences in obstructive sleep apnea (OSA) and increased aldosterone level may explain the racial disparity in resistant hypertension prevalence. Therefore, the purpose of this study is to investigate if aldosterone level and hypertension status differ by risks for OSA (e.g., obesity, loud snoring, and daytime sleepiness) and how aldosterone level varies with hypertension severity and control among African Americans. METHODS: A cross-sectional analysis was performed using baseline data on 5,052 African American adults in the Jackson Heart Study to investigate the relationships of interest using multivariable linear and multinomial logistic regression models adjusted for potential confounders. Risks for OSA were defined by a "risk score" consisting of the number of risks for OSA. RESULTS: Of the 5,052 participants, 623 had no risks for OSA. Body mass index was the highest among those with a risk score of 6. About 39% of the sample had no hypertension, 29% had controlled hypertension, 26% had uncontrolled hypertension, and 6% had resistant hypertension. Higher odds of having uncontrolled hypertension or resistant hypertension were present in those with a higher risk score compared with those without risks for OSA. Log-aldosterone level increased with each additional risk for OSA (P-trend <0.05). Similarly, log-aldosterone also increased with more severe hypertension (P-trend <0.001). The highest aldosterone level was found in those with resistant hypertension that was inadequately controlled with medications. CONCLUSIONS: Risks for OSA were positively associated with resistant hypertension and higher aldosterone level in African American adults.
Authors: George T O'Connor; Bonnie K Lind; Elisa T Lee; F Javier Nieto; Susan Redline; Jonathan M Samet; Lori L Boland; Joyce A Walsleben; Gregory L Foster Journal: Sleep Date: 2003-02-01 Impact factor: 5.849
Authors: Pia Holland Gjørup; Laima Sadauskiene; Jost Wessels; Ole Nyvad; B Strunge; Erling Bjerregaard Pedersen Journal: Am J Hypertens Date: 2007-01 Impact factor: 2.689
Authors: Jackson T Wright; Lawrence Agodoa; Gabriel Contreras; Tom Greene; Janice G Douglas; James Lash; Otelio Randall; Nancy Rogers; Michael C Smith; Shaul Massry Journal: Arch Intern Med Date: 2002-07-22
Authors: Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White Journal: Hypertension Date: 2018-11 Impact factor: 10.190